[1] Masoudkabir F,Sarrafzadegan N,Gotay C,et al. Cardiovascular disease and cancer: evidence for shared disease pathways and pharmacologic prevention [J]. Atherosclerosis,2017,263:343-351. [2] Giza D E,Iliescu G,Hassan S,et al. Cancer as a risk factor for cardiovascular disease [J]. Curr Oncol Rep,2017,19(6):39. [3] de Boer R A,Meijers W C,van der Meer P,et al. Cancer and heart disease: associations and relations [J]. Eur J Heart Fail,2019,21(12):1515-1525. [4] Liu Y,Ghesani N V,Zuckier L S. Physiology and pathophysiology of incidental findings detected on FDG-PET scintigraphy [J]. Semin Nucl Med,2010,40(4):294-315. [5] 武姣彦,王丽,杨敏福. 肿瘤PET/CT显像患者的心脏异常分析 [J]. 中华心血管病杂志, 2020,48(11):936-941. [6] Joseph P,Tawakol A. Imaging atherosclerosis with positron emission tomography [J]. Eur Heart J,2016,37(39):2974-2980. [7] Toczek J,Hillmer A T,Han J,et al. FDG PET imaging of vascular inflammation in post-traumatic stress disorder: A pilot case-control study [J]. J Nucl Cardiol,2019 May 9:10.1007/s12350-019-01724-w. [8] Bauckneht M,Ferrarazzo G,Fiz F,et al. Doxorubicin effect on myocardial metabolism as a prerequisite for subsequent development of cardiac toxicity: a translational 18F-FDG PET/CT observation [J]. J Nucl Med,2017,58(10):1638-1645. [9] Heckmann M B,Totakhel B,Finke D,et al. Evidence for a cardiac metabolic switch in patients with Hodgkin’s lymphoma [J]. ESC Heart Fail,2019,6(4):824-829. [10]Sarocchi M,Bauckneht M,Arboscello E,et al. An increase in myocardial 18-fluorodeoxyglucose uptake is associated with left ventricular ejection fraction decline in Hodgkin lymphoma patients treated with anthracycline [J]. J Transl Med,2018,16(1):295. [11]Slart R H J A,Glaudemans A W J M,Lancellotti P,et al. A joint procedural position statement on imaging in cardiac sarcoidosis: from the Cardiovascular and Inflammation & Infection Committees of the European Association of Nuclear Medicine, the European Association of Cardiovascular Imaging, and the American Society of Nuclear Cardiology [J]. J Nucl Cardiol,2018,25(1):298-319. [12]Kandathil A,Kay F U,Butt Y M,et al. Role of FDG PET/CT in the eighth edition of TNM staging of non-small cell lung cancer [J]. Radiographics,2018,38(7): 2134-2149. [13]Osborn E A,Kessinger C W,Tawakol A,et al. Metabolic and molecular imaging of atherosclerosis and venous thromboembolism [J]. J Nucl Med,2017,58(6):871-877. [14]Figueroa A L,Abdelbaky A,Truong Q A,et al. Measurement of arterial activity on routine FDG PET/CT images improves prediction of risk of future CV events [J]. JACC Cardiovasc Imaging,2013,6(12):1250-1259. [15]Xie B,Chen B X,Wu J Y,et al. Factors relevant to atrial 18F-fluorodeoxyglucose uptake in atrial fibrillation [J]. J Nucl Cardiol,2018,27(5):1501-1512. [16]Singh N,Baby D,Rajguru J P,et al. Inflammation and cancer [J]. Ann Afr Med,2019,18(3):121-126. [17]Ansaldo A M,Montecucco F,Sahebkar A,et al. Epicardial adipose tissue and cardiovascular diseases [J]. Int J Cardiol,2019,278:254-260. |